Inhibition of <i>KRAS</i> -Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit

Zehua Zhu, David A. Barbie(Dana-Farber Cancer Institute), Travis J. Cohoon(Broad Institute), Whitney Silkworth(Massachusetts General Hospital), Pablo Tamayo(Dana-Farber Cancer Institute), Kwok‐Kin Wong(NYU Langone Health), Ryan B. Corcoran(Massachusetts General Hospital), Jeffrey A. Engelman(Cancer Research Center), Michael J. Eck(Harvard University), Nir Hacohen(Cambridge Hospital), Thanh U. Barbie(Brigham and Women's Hospital), Susan E. Moody(Broad Institute), Tran C. Thai(Dana-Farber Cancer Institute), Karolina Maciag(Seattle Children's Hospital), William E. Gillanders(Washington University in St. Louis), Yu Imamura(Japanese Foundation For Cancer Research), Jason Godfrey(Broad Institute), William C. Hahn(Broad Institute), Asher N. Page(Broad Institute), Lior Rozhansky(Broad Institute), Shuji Ogino(Broad Institute), Jill P. Mesirov(University of California San Diego), Amir Reza Aref(Massachusetts General Hospital), Rhine R. Shen(Broad Institute), Zhi Rong Qian(Dana-Farber Cancer Institute), Suzanne Gaudet(Harvard University), Jacob B. Reibel(Broad Institute), Shenghong Yang(Chongqing Jiulongpo People's Hospital), Edmond M. Chan(Broad Institute), Anna C. Schinzel(Broad Institute), Mary T. Labowsky(Broad Institute)
Cancer Discovery
January 20, 2014
Cited by 195


Related Papers